This episode delves into the emerging role of GLP-1 receptor agonists, like semaglutide, in aesthetic medicine. Known for aiding with diabetes and obesity by promoting weight loss, these medications also introduce aesthetic challenges such as facial volume loss and skin laxity. The episode discusses how practitioners are using dermal fillers, energy-based devices, and surgical options to address these issues and the importance of a personalized approach to treatment. It also covers the need for aesthetic professionals to understand the physical and psychological effects of significant weight change to improve patient outcomes and satisfaction.
Stay connected with Dr. Teri Fisher and explore the latest in AI and automation for healthcare:
🎥 Watch on YouTube for in-depth AI tutorials: YouTube.com/@DrTeriFisher
📲 Follow on Instagram for automation tips: @DrTeriFisher
💡 Discover AI tools for your practice: DrTeriFisher.com
🎙 Listen to the long-form podcast: Anti-Aging Insights
👉 Subscribe to AI Automation Minute for your daily dose of AI-powered efficiency, and share with colleagues who want to work smarter, not harder!
#AIAutomationMinute #DrTeriFisher #HealthcareAI
